Cargando…

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension

OBJECTIVE: We investigated the effects of bisoprolol and losartan on subjects with essential hypertension, by conducting heart rate variability (HRV) analysis of ECG signals. Our intention was to establish the set of linear and nonlinear heart rate variability parameters, which could be used as a no...

Descripción completa

Detalles Bibliográficos
Autores principales: Keković, Goran, Milovanović, Branislav, Davidović, Dragomir, Raković, Dejan, Ćulić, Milka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702083/
https://www.ncbi.nlm.nih.gov/pubmed/23833576
_version_ 1782275752192901120
author Keković, Goran
Milovanović, Branislav
Davidović, Dragomir
Raković, Dejan
Ćulić, Milka
author_facet Keković, Goran
Milovanović, Branislav
Davidović, Dragomir
Raković, Dejan
Ćulić, Milka
author_sort Keković, Goran
collection PubMed
description OBJECTIVE: We investigated the effects of bisoprolol and losartan on subjects with essential hypertension, by conducting heart rate variability (HRV) analysis of ECG signals. Our intention was to establish the set of linear and nonlinear heart rate variability parameters, which could be used as a noninvasive markers in the treatment of hypertension. MATERIALS AND METHODS: Sixty subjects with essential hypertension included in this study were divided in two groups. During the four weeks medical treatment, the first group was administered with daily oral dose of 5 mg of bisoprolol and the second with daily oral dose of 50 mg of losartan. We recorded ECG signals, and performed HRV analysis of consecutive RR time intervals, before and after a month of pharmacological therapy. RESULTS: In the case of bisoprolol, statistically the most significant changes of HRV parameters were: TP (1814.1 ± 1731.3 ms(2) vs. 761.3 ± 725.0 ms(2), P < 0.0001), RR (870.2 ± 105.7 ms vs. 1027.2 ± 150.0 ms, P < 0.0001), HR (70.81 ± 8.42 bp/min vs. 60.10 ± 9.52 bp/min, P < 0.0001). In the case of losartan, the most significant changes were: SDNN (43.16 ± 17.27 ms vs. 237.98 ± 118.54 ms, P = 0.002), rmSDD (27.09 ± 18.27 ms vs. 46.82 ± 37.71 ms, P = 0.003), SD2 (55.18 ± 20.6 vs. 70.67 ± 26.12, P < 0.019) and DF2 (0.69 ± 0.21 vs. 0.86 ± 0.25, P < 0.014). CONCLUSION: Effects of bisoprolol and losartan were especially manifested among the set of linear HRV parameters. As a consequence of effect of losartan, we singled out the nonlinear parameters SD2 and DF2.
format Online
Article
Text
id pubmed-3702083
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37020832013-07-05 Comparative effect of bisoprolol and losartan in the treatment of essential hypertension Keković, Goran Milovanović, Branislav Davidović, Dragomir Raković, Dejan Ćulić, Milka J Res Med Sci Original Article OBJECTIVE: We investigated the effects of bisoprolol and losartan on subjects with essential hypertension, by conducting heart rate variability (HRV) analysis of ECG signals. Our intention was to establish the set of linear and nonlinear heart rate variability parameters, which could be used as a noninvasive markers in the treatment of hypertension. MATERIALS AND METHODS: Sixty subjects with essential hypertension included in this study were divided in two groups. During the four weeks medical treatment, the first group was administered with daily oral dose of 5 mg of bisoprolol and the second with daily oral dose of 50 mg of losartan. We recorded ECG signals, and performed HRV analysis of consecutive RR time intervals, before and after a month of pharmacological therapy. RESULTS: In the case of bisoprolol, statistically the most significant changes of HRV parameters were: TP (1814.1 ± 1731.3 ms(2) vs. 761.3 ± 725.0 ms(2), P < 0.0001), RR (870.2 ± 105.7 ms vs. 1027.2 ± 150.0 ms, P < 0.0001), HR (70.81 ± 8.42 bp/min vs. 60.10 ± 9.52 bp/min, P < 0.0001). In the case of losartan, the most significant changes were: SDNN (43.16 ± 17.27 ms vs. 237.98 ± 118.54 ms, P = 0.002), rmSDD (27.09 ± 18.27 ms vs. 46.82 ± 37.71 ms, P = 0.003), SD2 (55.18 ± 20.6 vs. 70.67 ± 26.12, P < 0.019) and DF2 (0.69 ± 0.21 vs. 0.86 ± 0.25, P < 0.014). CONCLUSION: Effects of bisoprolol and losartan were especially manifested among the set of linear HRV parameters. As a consequence of effect of losartan, we singled out the nonlinear parameters SD2 and DF2. Medknow Publications & Media Pvt Ltd 2012-11 /pmc/articles/PMC3702083/ /pubmed/23833576 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Keković, Goran
Milovanović, Branislav
Davidović, Dragomir
Raković, Dejan
Ćulić, Milka
Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
title Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
title_full Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
title_fullStr Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
title_full_unstemmed Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
title_short Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
title_sort comparative effect of bisoprolol and losartan in the treatment of essential hypertension
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702083/
https://www.ncbi.nlm.nih.gov/pubmed/23833576
work_keys_str_mv AT kekovicgoran comparativeeffectofbisoprololandlosartaninthetreatmentofessentialhypertension
AT milovanovicbranislav comparativeeffectofbisoprololandlosartaninthetreatmentofessentialhypertension
AT davidovicdragomir comparativeeffectofbisoprololandlosartaninthetreatmentofessentialhypertension
AT rakovicdejan comparativeeffectofbisoprololandlosartaninthetreatmentofessentialhypertension
AT culicmilka comparativeeffectofbisoprololandlosartaninthetreatmentofessentialhypertension